or Try an Advanced Search...

    Technical Analysis for UNCY - Unicycive Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.54 7.76% 0.04
    UNCY closed up 7.76 percent on Monday, July 1, 2024, on 2.32 times normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical UNCY trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Lower Bollinger Band Walk Weakness 7.76%
    Wide Bands Range Expansion 7.76%
    Lower Bollinger Band Touch Weakness 7.76%
    Oversold Stochastic Weakness 7.76%
    New 52 Week Closing Low Bearish 33.30%
    Older End-of-Day Signals for UNCY ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 9 hours ago
    2x Volume Pace about 9 hours ago
    1.5x Volume Pace about 9 hours ago
    3x Volume Pace about 9 hours ago
    Up 5% about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    UNCY Chart by TradingView
    Basic chart:

    Profile

    Unicycive is a biotechnology company developing novel treatment for kidney diseases. Unicycive's lead drug, Renazorb, is a novel phosphate binding agent being developed for the treatment of hyperphosphatemia. UNI-494 is a patent protected new chemical entity in late preclinical development for the treatment of acute kidney injury
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Kidney Disease Kidney Nephrology Organ Failure Acute Kidney Injury Hyperphosphatemia Chemical Entity

    Is UNCY a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 21 When Can We Expect A Profit From Unicycive Therapeutics, Inc. (NASDAQ:UNCY)?
    May 28 Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress
    May 15 Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting
    May 14 Unicycive Therapeutics reports Q1 GAAP EPS of -$0.61
    Apr 29 These 2 ‘Strong Buy’ Penny Stocks Could Rally to $9, Says Piper Sandler
    Mar 28 Unicycive Therapeutics GAAP EPS of -$1.28, revenue of $0.7M
    Mar 28 Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
    Mar 25 Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress
    Mar 14 Unicycive rises 4% on $50M private placement
    Mar 14 Unicycive Announces $50 Million Private Placement
    See more UNCY news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.818
    52 Week Low 0.339
    Average Volume 696,908
    200-Day Moving Average 0.93
    50-Day Moving Average 0.89
    20-Day Moving Average 0.65
    10-Day Moving Average 0.57
    Average True Range 0.08
    RSI (14) 35.90
    ADX 39.28
    +DI 21.16
    -DI 41.30
    Chandelier Exit (Long, 3 ATRs) 0.71
    Chandelier Exit (Short, 3 ATRs) 0.59
    Upper Bollinger Bands 0.89
    Lower Bollinger Band 0.41
    Percent B (%b) 0.27
    BandWidth 73.61
    MACD Line -0.12
    MACD Signal Line -0.12
    MACD Histogram -0.0028
    Fundamentals Value
    Market Cap 18.77 Million
    Num Shares 34.8 Million
    EPS -1.47
    Price-to-Earnings (P/E) Ratio -0.37
    Price-to-Sales 57.15
    Price-to-Book 11.69
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.62
    Resistance 3 (R3) 0.62 0.59 0.61
    Resistance 2 (R2) 0.59 0.57 0.59 0.60
    Resistance 1 (R1) 0.57 0.56 0.57 0.57 0.60
    Pivot Point 0.54 0.54 0.54 0.54 0.54
    Support 1 (S1) 0.51 0.52 0.51 0.51 0.48
    Support 2 (S2) 0.49 0.51 0.49 0.48
    Support 3 (S3) 0.46 0.49 0.48
    Support 4 (S4) 0.46